SaMD Series: What Should Life Sciences Companies Know?
August 14, 2018
Software as a Medical Device – also referred to as SaMD – is one of the fastest growing innovations in the medical device industry. As with any technology that experiences rapid adoption, challenges related to IP protection often follow. In this series, we’re taking a closer look at IP considerations that SaMD developers should be aware of.
In this podcast, Finnegan attorneys Eric Raciti and Cory Bell explore nuances of IP law that life sciences companies should consider when developing an SaMD.
Downloadable Files
Related Offices
Related Professionals
- Eric P. Raciti
- Partner
- Boston, MA
- +1 617 646 1675
- Cory C. Bell
- Partner
- Boston, MA
- +1 617 646 1641
